No volunteers for India’s injectable vasectomy

GlobalPost

An Indian effort to pioneer a non-surgical, reversible vasectomy has run into an unexpected hurdle, as researchers are having difficulty finding volunteers for clinical trials of the new treatment, the Times of India reports.

The treatment, called RISUG (Reversible Inhibition of Sperm UnderGuidance), has already shown great promise in earlier phases of testing, as detailed earlier this year in GlobalPost. 

According to the TOI, however, the phase-III trials which started in four centres in 2009 has only managed to recruit around 60 male volunteers against a target of 200 (around 50 volunteers per center). In response, the Indian Council for Medical Research has asked regulators for permission to extend the trials to four more centers.

Will you support The World with a monthly donation?

Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you. We need your support to ensure we can continue this work for another year.

Make a gift today, and you’ll help us unlock a matching gift of $67,000!